Where research is preliminary, this is flagged in the text. Absence of long-term human data should be assumed for most peptides covered here.
In Canada, the starting dose of tirzepatide for weight loss is 2.5 mg injected subcutaneously once weekly for the first four weeks. This low initial dose helps your body adjust while minimizing side effects like nausea. After that, the dose increases every four weeks based on a standard titration schedule, reaching up to 15 mg weekly if needed and tolerated.
What Is the Recommended Tirzepatide Starting Dose for Weight Loss?
The tirzepatide weight loss starting dose is 2.5 mg once weekly. This is not yet a therapeutic dose for weight reduction but a step to build tolerance. You stay on 2.5 mg for exactly four weeks. Some people notice appetite suppression early, but significant weight loss typically begins at higher doses. Do not rush this phase; your body needs time to adapt to the medication's effects on gastric emptying and appetite centers.
In Canada, tirzepatide is approved under the brand name Mounjaro for type 2 diabetes, but it is widely prescribed off-label for weight management. The dosing protocol for weight loss mirrors the diabetes titration schedule. Always use a new needle for each injection and rotate sites (abdomen, thigh, or upper arm). If you miss a dose, take it as soon as possible within 4 days; otherwise skip it and resume your regular schedule.
Tirzepatide Titration Schedule: Step-by-Step Increases
The standard tirzepatide titration schedule increases the dose every four weeks in 2.5 mg increments. Here is the typical progression:
- Weeks 1–4: 2.5 mg once weekly
- Weeks 5–8: 5 mg once weekly
- Weeks 9–12: 7.5 mg once weekly
- Weeks 13–16: 10 mg once weekly
- Weeks 17–20: 12.5 mg once weekly
- Week 21 onward: 15 mg once weekly (maintenance)
Not everyone needs to reach 15 mg. Many people achieve their weight loss goals at 5 mg or 7.5 mg. Your doctor will adjust based on your response and side effects. If you experience intolerable nausea or other gastrointestinal issues, you may stay at a lower dose longer or even step back down. The goal is the lowest effective dose.
Clinical trials showed that higher doses lead to greater weight loss on average. In the SURMOUNT-1 trial, participants on 15 mg lost up to 22.5% of body weight over 72 weeks. However, individual results vary. Some people are super-responders at 5 mg. Patience and consistent weekly injections are key.
How to Inject Tirzepatide Correctly
Tirzepatide comes in a pre-filled single-dose pen. Each pen contains one weekly dose. Before injecting, check the liquid is clear and colorless. Do not use if cloudy or discolored. Clean the injection site with an alcohol swab. Pinch the skin, insert the needle at a 90-degree angle, and press the button until it clicks. Hold for 10 seconds to ensure full delivery. Dispose of the pen in a sharps container.
You can inject at any time of day, with or without food. If you forget and remember within 4 days (96 hours), take the missed dose. If more than 4 days have passed, skip it and take your next dose on the regular day. Never double up doses. Changing your injection day is okay as long as at least 3 days have passed since the last dose.
For those in Canada buying tirzepatide from online peptide vendors, note that it often comes as a lyophilized powder requiring reconstitution. This is a different process than the brand-name pens. You will need bacteriostatic water, insulin syringes, and sterile technique. Always verify the source's quality, as Canadian regulations for research peptides differ from approved pharmaceuticals. When you explore peptide options in Quebec, ensure you understand reconstitution protocols.
Managing Side Effects During Titration
Gastrointestinal side effects are most common during dose increases. Nausea, diarrhea, vomiting, and constipation affect up to 30% of users. These usually peak in the first few days after a dose increase and subside over time. To reduce nausea, eat smaller, blander meals and avoid high-fat or fried foods. Stay hydrated. Some doctors prescribe anti-nausea medication temporarily.
More serious but rare side effects include pancreatitis, gallbladder problems, and kidney injury. Stop tirzepatide and seek medical attention if you have severe abdominal pain that does not go away, with or without vomiting. Also watch for signs of allergic reaction: rash, itching, swelling of face or throat. Tirzepatide carries a boxed warning for thyroid C-cell tumors in rodents; it is unknown if it causes these in humans. Do not use if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Weight loss itself can lead to changes in body composition. Some people worry about loose skin after significant weight loss. While tirzepatide does not directly affect skin elasticity, rapid fat loss may contribute to sagging. You might find interest in peptides for skin firmness after weight loss as a complementary approach.
Tirzepatide Dosing for Special Populations
For patients with mild kidney impairment, no dose adjustment is needed. For moderate to severe kidney disease, use caution and monitor kidney function. There is limited data in end-stage renal disease. In liver impairment, no dose adjustment is required. However, tirzepatide has not been studied in severe liver disease. Elderly patients can use the same dosing schedule, but they may be more sensitive to side effects.
If you are switching from another GLP-1 receptor agonist like semaglutide, your doctor will decide the starting dose. Typically, you start at 2.5 mg tirzepatide regardless of prior semaglutide dose, due to differences in receptor activity. Tirzepatide is a dual GIP/GLP-1 agonist, which may offer greater efficacy. Some Canadian clinics are now using tirzepatide as a first-line obesity treatment.
Combining tirzepatide with other weight loss peptides is not recommended without medical supervision. However, some researchers explore stacks for muscle preservation or recovery. For instance, BPC-157 and TB-500 are popular for muscle recovery in Canada, but their interaction with tirzepatide is unstudied. Always prioritize safety.
Where to Find Tirzepatide in Canada
In Canada, tirzepatide is available by prescription as Mounjaro. It is not yet approved specifically for weight loss, but many doctors prescribe it off-label. Coverage varies by province and private insurance. Without coverage, the cost can exceed $300 per month. Some Canadians turn to compounding pharmacies or research peptide suppliers for more affordable options. When buying tirzepatide online, verify the vendor's third-party testing and reviews.
If you are in Quebec, local regulations may affect access. Peptide vendors often ship nationwide, but customs can seize unapproved imports. Always check the legal status in your province. For those interested in other peptides, topical peptides like Argireline are popular in Quebec for cosmetic purposes, but they serve a different function than metabolic peptides.
Frequently Asked Questions About Tirzepatide Dosing
Can I start at a higher dose than 2.5 mg?
No. Starting at 2.5 mg is critical to reduce gastrointestinal side effects. Skipping the initiation phase greatly increases the risk of severe nausea and vomiting. Even if you have used other GLP-1 drugs, follow the 2.5 mg start.
How long should I stay at each dose?
At least 4 weeks. Some people stay on a dose longer if they are losing weight steadily and tolerating it well. There is no rush to reach the maximum dose. The titration schedule is a guideline, not a race.
What if I plateau on a dose?
Weight loss plateaus are normal. If you have not lost weight for 4 weeks on a given dose, your doctor may recommend moving to the next level. However, also review your diet and exercise. Tirzepatide works best with lifestyle changes.
Is there a maximum tirzepatide dosage?
15 mg once weekly is the highest studied and approved dose. Doses above 15 mg have not been tested in clinical trials and are not recommended. Do not exceed this without direct medical supervision.
Can I split my dose into twice-weekly injections?
This is not standard. The once-weekly dosing is designed for convenience and sustained receptor activation. Some people experiment with splitting to reduce side effects, but there is no clinical data supporting this. Always consult your doctor before altering the regimen.
Monitoring Your Progress on Tirzepatide
Track your weight weekly, but don't obsess over daily fluctuations. Measure your waist circumference monthly. Note any side effects and their severity. Keep a food diary to ensure adequate protein and nutrient intake. Rapid weight loss can cause muscle loss, so prioritize strength training and protein. Your doctor will monitor your A1C if you have diabetes, and may check kidney and liver function periodically.
Remember that tirzepatide is a tool, not a cure. Sustainable weight loss requires long-term habits. Some people regain weight after stopping the medication. Discuss a maintenance plan with your healthcare provider, which may involve a lower maintenance dose or intermittent use.
In summary, the tirzepatide dosage Canada protocol starts at 2.5 mg weekly and increases every 4 weeks by 2.5 mg, up to 15 mg. This gradual tirzepatide titration schedule balances efficacy and tolerability. Always work with a Canadian healthcare professional to tailor the plan to your needs.